EyeSpy.org Logo
  • Directory
  • Events
  • News
  • Media
  • About
  • Contact
Donate
EyeSpy.org Logo
  • Home
  • Directory
  • Events
  • News
  • Media
  • Contact Us
  • Donate
Eye on the Cure Podcast | Episode 105: A Race Against Blindness

Eye on the Cure Podcast | Episode 105: A Race Against Blindness

Nov 4, 2026 | Media, News, Podcast

Dr. Steven Johnston, co-founder of the non-profit organization A Race Against Blindness, talks about his son’s diagnosis with Bardet-Biedl syndrome – a rare genetic condition that causes progressive vision loss, his partnership with the Foundation Fighting Blindness...
Eye on the Cure Podcast | Episode 105: A Race Against Blindness

Emerging gene therapy for RDH12-associated Leber congenital amaurosis cleared for clinical trials

Oct 23, 2026 | Media, News, Podcast

An emerging gene therapy treatment for Leber congenital amaurosis (LCA) received the green light from the U.S. Food and Drug Administration to proceed with clinical trials in people, bringing it one step closer to patients with a rare form of childhood blindness. The...
Eye on the Cure Podcast | Episode 105: A Race Against Blindness

Eye on the Cure | Episode 104: Emerging XLRP gene therapy shows promising clinical trial results

Oct 21, 2026 | Media, News, Podcast

Host Maddie Mossman talks with Dr. Daniel Chung, Chief Medical Officer of Beacon Therapeutics, about Laru-zova, an emerging treatment for X-linked retinitis pigmentosa. Based on encouraging clinical trial results, Beacon plans to begin a rolling FDA submission for the...
Eye on the Cure Podcast | Episode 105: A Race Against Blindness

PRPH2 Workshop 2026: Day 1 Keynote – John Samuel

Oct 5, 2026 | Media, News, Podcast

PRPH2 Workshop 2026: Day 1 Keynote – John Samuel by Foundation Fighting...
Eye on the Cure Podcast | Episode 105: A Race Against Blindness

Early clinical trial results show vision gains in patients with BEST1-related disease

Oct 2, 2026 | Media, News, Podcast

Opus Genetics has shared encouraging early results from its ongoing Phase 1/2 clinical trial for OPGx-BEST1, a potential one-time gene therapy for people with BEST1-related retinal disease. All five patients enrolled in the clinical trial had clinically meaningful...
Eye on the Cure Podcast | Episode 105: A Race Against Blindness

Beacon’s emerging XLRP gene therapy improves low-light vision in phase 3 trial

Sep 22, 2026 | Media, News, Podcast

Beacon Therapeutics reported positive results from the Phase 3 pivotal trial of laru-zova, its potential gene therapy treatment for X-linked retinitis pigmentosa. A significant proportion of patients improved dim-light vision by 15 or more letters after treatment with...
« Older Entries

Recent Posts

  • Episode 84 – VP accessibility at AIRA – Jeff Wissel
  • Coach Willie Blake on Embracing Dyslexia and Finding Your Strengths
  • Wide-Field Fundus Autofluorescence Patterns in a Polish Cohort of Genotyped Patients with Phenotype of Retinitis Pigmentosa, Usher Syndrome and Cone-Rod Dystrophy
  • An extremly rare retinal disease is stealing my father’s sight — Genetic testing revealed a previously undocumented CACNA2D4 variant.
  • Future Leader Dog Lumi November Update

Recent Comments

No comments to show.

About

The Eye Spy Foundation, a 501(c)(3) non-profit, is dedicated to enhancing digital accessibility for the blind and low-vision community, fostering empowerment and connection through innovative web solutions.

Links

$

Directory

$

News

$

Events

$

Media

Connect



1-844-222-8848



[email protected]

l

Contact Us

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Give

Donate
Eye Spy Foundation Logo

Copyright © 2024 – Current |Eye Spy Foundation.